Searches , social queries for GRAFT VERSUS-HOST-DISEASE

Search references for GRAFT VERSUS-HOST-DISEASE. Phrases containing GRAFT VERSUS-HOST-DISEASE

See searches and references containing GRAFT VERSUS-HOST-DISEASE!

Searches containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

  • Graft-versus-host disease
  • Rejection of host tissue by a transplanted organ's immune cells

    Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. GvHD is commonly associated with bone marrow transplants

    Graft-versus-host disease

    Graft-versus-host disease

    Graft-versus-host_disease

  • Transfusion-associated graft-versus-host disease
  • Rejection of host cells by the immune cells of transplanted blood

    In hematology, transfusion-associated graft-versus-host disease (TA-GvHD) is a rare complication of blood transfusion, in which the immunologically competent

    Transfusion-associated graft-versus-host disease

    Transfusion-associated_graft-versus-host_disease

  • Hematopoietic stem cell transplantation
  • Medical procedure to replace blood or immune stem cells

    radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic HSCT. HSCT remains a dangerous

    Hematopoietic stem cell transplantation

    Hematopoietic stem cell transplantation

    Hematopoietic_stem_cell_transplantation

  • Anti-thymocyte globulin
  • Antibodies to prevent and treat transplant rejection

    acute graft versus host disease in recipients receiving progenitor cell transplants. While higher doses (15 mg/kg) reduced acute graft versus host this

    Anti-thymocyte globulin

    Anti-thymocyte_globulin

  • Cyclophosphamide
  • Medication used as chemotherapy and to suppress the immune system

    people who are ill-suited for autologous stem cell transplant. Graft-versus-host disease (GVHD) is a major barrier for allogeneic stem cell transplant

    Cyclophosphamide

    Cyclophosphamide

    Cyclophosphamide

  • Sirolimus
  • Pharmaceutical drug

    DA (June 1998). "Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production

    Sirolimus

    Sirolimus

    Sirolimus

  • Graft-versus-tumor effect
  • myeloma and possibly breast cancer. It is closely linked with graft-versus-host disease (GvHD), as the underlying principle of alloimmunity is the same

    Graft-versus-tumor effect

    Graft-versus-tumor_effect

  • Allotransplantation
  • Transplantation between individuals of the same species

    transplant can result in an immune attack on the recipient, called graft-versus-host disease. Material is obtained from a donor who is a living person, or

    Allotransplantation

    Allotransplantation

  • Lichen planus
  • Human chronic inflammatory disease

    lichenoid reactions. They can also occur in association with graft versus host disease. Lichen planus lesions are so called because of their "lichen-like"

    Lichen planus

    Lichen_planus

  • Inflammatory cytokine
  • Type of signaling molecule

    involved the detrimental effects of renal fibrosis.[citation needed] Graft-versus-host disease (GvHD) targets JAK 1 and 2, the human tyrosine kinase protein

    Inflammatory cytokine

    Inflammatory_cytokine

  • Cytokine storm
  • Frequently fatal immune reaction

    group A streptococcus, and non-infectious conditions such as graft-versus-host disease. The viruses can invade lung epithelial cells and alveolar macrophages

    Cytokine storm

    Cytokine_storm

  • Belumosudil
  • Chemical compound

    among others, is a medication used for the treatment of chronic graft versus host disease (cGvHD). It is in the class of drugs known as serine/threonine

    Belumosudil

    Belumosudil

    Belumosudil

  • LPAM-1
  • Protein complex

    therapeutics. LPAM-1 integrin is involved in the development of graft-versus-host disease (GVHD). Donor-derived CTL cells use α4β7 integrin to migrate to

    LPAM-1

    LPAM-1

  • Transplant rejection
  • Rejection of transplanted tissue by the recipient's immune system

    rejection via the CD4 and CD8 T cells. Complication (medicine) Graft-versus-host disease Graft-versus-tumor effect Immunosuppression Transplant engineering Li

    Transplant rejection

    Transplant rejection

    Transplant_rejection

  • Thymus transplantation
  • Form of organ transplantation

    Theoretically, thymus transplantation could cause two types of graft-versus-host disease (GVHD): First, it could cause a donor T cell-related GVHD, because

    Thymus transplantation

    Thymus_transplantation

  • Thalidomide
  • Immunomodulatory drug

    currently used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such

    Thalidomide

    Thalidomide

    Thalidomide

  • Ruxolitinib
  • Medication

    to or intolerance of hydroxyurea; and steroid-refractory acute graft-versus-host disease. Ruxolitinib is a Janus kinase inhibitor. It was developed and

    Ruxolitinib

    Ruxolitinib

    Ruxolitinib

  • Timothy Ray Brown
  • First person known to have been cured of HIV/AIDS

    that when a transplant recipient has graft-versus-host disease, the transplanted cells may kill off the host's HIV-infected immune cells. In July 2012

    Timothy Ray Brown

    Timothy Ray Brown

    Timothy_Ray_Brown

  • Alemtuzumab
  • Medication

    (no controls) with severe steroid-resistant acute intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (HSCT)

    Alemtuzumab

    Alemtuzumab

    Alemtuzumab

  • Mesoblast
  • Australian pharmaceutical company

    sold it as an allogeneic cell product for the treatment of acute graft versus host disease (aGVHD) in children and adults in Japan. TEMCELL is the first

    Mesoblast

    Mesoblast

  • Purinergic signalling
  • Biological communication between cells involving purine nucleosides and their receptors

    in patients with Graft-versus-host disease (GVHD), ATP is released into the peritoneal fluid. It binds onto the P2RX7 receptors of host antigen-presenting

    Purinergic signalling

    Purinergic signalling

    Purinergic_signalling

  • Ibrutinib
  • Medication used in cancer treatment

    macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic graft versus host disease (cGVHD). Very common (>10% frequency) adverse effects include

    Ibrutinib

    Ibrutinib

    Ibrutinib

  • Multiple myeloma
  • Cancer of plasma cells

    donor (allograft). Allografts come with a particular risk of a graft-versus-host-disease. Mesenchymal stromal cells may reduce all-cause mortality if they

    Multiple myeloma

    Multiple myeloma

    Multiple_myeloma

  • Acute lymphoblastic leukemia
  • Blood cancer characterized by overproduction of lymphoblasts

    treating graft-versus-host disease after stem cell transplantation on all-cause mortality and the complete disappearance of chronic acute graft-versus-host disease

    Acute lymphoblastic leukemia

    Acute lymphoblastic leukemia

    Acute_lymphoblastic_leukemia

  • Hurler syndrome
  • Genetic disorder

    cognitive function, and physical symptoms. Patients can develop graft versus host disease; this is more likely in non-sibling donors. In a 1998 study, children

    Hurler syndrome

    Hurler syndrome

    Hurler_syndrome

  • Sjögren's disease
  • Autoimmune disease

    immunodeficiency syndrome, sarcoidosis, amyloidosis, graft-versus-host disease, and IgG4-related disease. Patients using anticholinergic drugs must stop using

    Sjögren's disease

    Sjögren's disease

    Sjögren's_disease

  • Hodgkin lymphoma
  • Type of blood and immune-system cancer

    stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with

    Hodgkin lymphoma

    Hodgkin lymphoma

    Hodgkin_lymphoma

  • Axatilimab
  • Monoclonal antibody

    Niktimvo, is a monoclonal antibody used for the treatment of chronic graft-versus-host disease. It is a blocker of the colony stimulating factor-1 receptor.

    Axatilimab

    Axatilimab

  • Apheresis
  • Medical techniques to separate one or more components of blood

    the units tested and that the product be irradiated to avoid graft-versus-host disease (inactivate lymphocytes). Irradiation does not affect PMN function

    Apheresis

    Apheresis

    Apheresis

  • Remestemcel
  • Pharmacologic substance

    marrow-derived mesenchymal stromal cell therapy used for the treatment of graft-versus-host disease. Remestemcel contains mesenchymal stromal cells, which are a type

    Remestemcel

    Remestemcel

  • Maculopapular rash
  • Skin rash of small, raised red bumps

    may also have this appearance. Maculopapular rash is seen in graft-versus-host disease (GVHD) developed after a hematopoietic stem cell transplant (bone

    Maculopapular rash

    Maculopapular rash

    Maculopapular_rash

  • Immunosuppression
  • Decreased resistance to infection

    it is used for treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as systemic lupus erythematosus

    Immunosuppression

    Immunosuppression

    Immunosuppression

  • Skin grafting
  • Surgical transplantation of skin

    forms. Risks for the skin graft surgery are: Bleeding Infection Loss of grafted skin Nerve damage Graft-versus-host disease Marjolin's ulcer Rejection

    Skin grafting

    Skin grafting

    Skin_grafting

  • Mesenchymal stem cell
  • Multipotent adult stem cells present in multiple tissues

    treating diseases are in clinical development around the world, particularly treating autoimmune diseases, graft versus host disease, Crohn's disease, multiple

    Mesenchymal stem cell

    Mesenchymal stem cell

    Mesenchymal_stem_cell

  • Ivarmacitinib
  • Chemical compound

    developed for ulcerative colitis, eczema, alopecia areata, and graft-versus-host disease. Chen, Baili; Zhong, Jie; Li, Xiuling; Pan, Feng; Ding, Yijuan;

    Ivarmacitinib

    Ivarmacitinib

    Ivarmacitinib

  • T-cell depletion
  • be induced for treatment purposes. TCD can reduce the risk of graft-versus-host disease (GvHD), which is a common issue in transplants. The idea that

    T-cell depletion

    T-cell_depletion

  • Isograft
  • immune system. Furthermore, there is virtually no incidence of graft-versus-host disease. In 1993 a research article demonstrated that islet isografts

    Isograft

    Isograft

  • Non-Hodgkin lymphoma
  • Type of cancer of lymph nodes

    participants receive stem-cell transplants, they can develop a graft-versus-host disease. When compared with placebo for treating immune mediated inflammation

    Non-Hodgkin lymphoma

    Non-Hodgkin lymphoma

    Non-Hodgkin_lymphoma

  • Blood irradiation therapy
  • Alternative medical procedure

    suggests that photopheresis might be effective in the treatment of graft-versus-host disease, though controlled trials are needed to support this use. The

    Blood irradiation therapy

    Blood_irradiation_therapy

  • Rainer F. Storb
  • allogeneic‐transplantation biology, prevention of graft-versus-host disease, conditioning regimen innovation, using the graft-versus-tumor effect as an early form of immunotherapy

    Rainer F. Storb

    Rainer F. Storb

    Rainer_F._Storb

  • NR58-3.14.3
  • Chemical compound

    number of disease models such as atherosclerosis, ischemia, lung disease, surgical adhesions, endometriosis and pulmonary graft-versus-host disease. It has

    NR58-3.14.3

    NR58-3.14.3

    NR58-3.14.3

  • Inolimomab
  • Monoclonal antibody

    monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.

    Inolimomab

    Inolimomab

  • Congenital athymia
  • Rare immune disorder where the thymus is missing at birth

    opportunistic infections, and a tendency to develop autologous graft-versus-host disease (GVHD) or, in the case of complete DiGeorge syndrome, an "atypical"

    Congenital athymia

    Congenital athymia

    Congenital_athymia

  • Stephanie Lee (scientist)
  • American haematologist and physician scientist

    bone marrow patients by better understanding the chronic form of graft-versus-host disease. Lee is the former president of the American Society of Hematology

    Stephanie Lee (scientist)

    Stephanie_Lee_(scientist)

  • Organ (biology)
  • Collection of tissues with similar functions

    often requires immunosuppression to prevent organ rejection or graft-versus-host disease. There is considerable interest throughout the world in creating

    Organ (biology)

    Organ (biology)

    Organ_(biology)

  • HLA-DR
  • Subclass of HLA-D antigens that consist of alpha and beta chains

    were originally defined as cell surface antigens that mediate graft-versus-host disease. Identification of these antigens has led to greater success and

    HLA-DR

    HLA-DR

    HLA-DR

  • Immune response
  • Reaction occurring within an organism as a defence against a pathogen

    (for example, blood) or organ can cause graft-versus-host disease. A type of immune reactivity known as Rh disease can be observed in pregnant women. These

    Immune response

    Immune_response

  • H. Joachim Deeg
  • German-American physician

    known for his work in hematopoietic stem cell transplantation, graft-versus-host disease, and the treatment of bone marrow failure syndromes, myelodysplastic

    H. Joachim Deeg

    H. Joachim Deeg

    H._Joachim_Deeg

  • List of autoimmune diseases
  • This article provides a list of autoimmune diseases. These conditions, where the body's immune system mistakenly attacks its own cells, affect a range

    List of autoimmune diseases

    List of autoimmune diseases

    List_of_autoimmune_diseases

  • Sickle cell disease
  • Medical condition

    HSCT can include graft-versus-host disease, failure of the graft, and other toxicity related to the transplant. Sickle cell disease is most prevalent

    Sickle cell disease

    Sickle cell disease

    Sickle_cell_disease

  • Bone grafting
  • Bone transplant

    Medicine portal Bone healing CNT Network Bio-Stress Sensors Graft-versus-host disease Hydroxyapatite Oral and Maxillofacial Surgery Orthopedic surgery

    Bone grafting

    Bone grafting

    Bone_grafting

  • Photopheresis
  • Medical intervention

    lymphoma. Evidence suggests that this treatment might help treat graft-versus-host disease, though this evidence is largely observational; controlled trials

    Photopheresis

    Photopheresis

  • Eosinophilia
  • Excess number of eosinophil cells in the blood

    fungi and viruses. They also participate in transplant rejection, Graft-versus-host disease, and the killing of tumor cells. In conducting these functions

    Eosinophilia

    Eosinophilia

    Eosinophilia

  • Chemotherapy-induced acral erythema
  • Reddening, swelling, numbness and skin peeling due to chemotherapy

    three weeks) graft-versus-host disease. It is important to differentiate PPE, which is benign, from the more dangerous graft-versus-host disease. As time

    Chemotherapy-induced acral erythema

    Chemotherapy-induced acral erythema

    Chemotherapy-induced_acral_erythema

  • TK cell therapy
  • Experimental leukemia treatment

    simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors"

    TK cell therapy

    TK_cell_therapy

  • HLA-DQ
  • Cell surface receptor protein found on antigen-presenting cells

    these D antigens, originally HL-A4 antigens, are involved in graft-versus-host disease when lymphoid tissues are transplanted between people. Serological

    HLA-DQ

    HLA-DQ

    HLA-DQ

  • Pimicotinib
  • Experimental drug

    investigated as a treatment for tenosynovial giant cell tumor, chronic graft-versus-host-disease (cGVHD), and pancreatic cancer. Vaynrub A, Healey JH, Tap W, Vaynrub

    Pimicotinib

    Pimicotinib

    Pimicotinib

  • Blood transfusion
  • Intravenous transference of blood products

    treatment can also replace gamma-irradiation as a method to prevent graft-versus-host disease (TA-GvHD). Before a recipient receives a transfusion, compatibility

    Blood transfusion

    Blood transfusion

    Blood_transfusion

  • Elizabeth Simpson (biologist)
  • British biologist

    and their roles in the generation of immunological tolerance, graft versus host disease, and transplant rejection. Elizabeth Simpson was born in London

    Elizabeth Simpson (biologist)

    Elizabeth_Simpson_(biologist)

  • Autoimmune enteropathy
  • Medical condition

    autoimmune enteropathy is graft-versus-host disease, Crohn's disease, and food sensitivity enteropathies such as celiac disease and lactose intolerance

    Autoimmune enteropathy

    Autoimmune enteropathy

    Autoimmune_enteropathy

  • Esophageal web
  • Abnormal membrane in the esophagus

    Syndrome, bullous dermatologic disorders, inlet patch, graft-versus-host disease, and celiac disease. The postulated mechanisms are sideropenic anemia (mechanism

    Esophageal web

    Esophageal web

    Esophageal_web

  • List of skin conditions
  • Lichenoid trikeratosis Lichenoid dermatitis Lichenoid reaction of graft-versus-host disease Linear lichen planus Mucosal lichen planus Peno-gingival syndrome

    List of skin conditions

    List of skin conditions

    List_of_skin_conditions

  • CAR-NK
  • Natural killer T cells genetically engineered to combat cancer

    advantages such as reduced risk of cytokine release syndrome (CRS) and graft-versus-host disease (GVHD), enabling "off-the-shelf" allogeneic use. As of 2025, CAR-NK

    CAR-NK

    CAR-NK

  • Siplizumab
  • Monoclonal antibody

    as a possible treatment for psoriasis and in the prevention of graft-versus-host disease. Podestà, Manuel A.; Binder, Christian; Sellberg, Felix; DeWolf

    Siplizumab

    Siplizumab

  • Entospletinib
  • Chemical compound

    lymphocytic leukemia (CLL), diffuse large B cell lymphoma (DLBCL), graft-versus-host disease (GvHD), hematological malignancies, mantle cell lymphoma (MCL)

    Entospletinib

    Entospletinib

    Entospletinib

  • Steven Z. Pavletic
  • developing consensus guidelines for clinical trials in chronic Graft-versus-host disease (GVHD). Pavletic (born Živko Pavletić) was born in Zagreb, Croatia

    Steven Z. Pavletic

    Steven Z. Pavletic

    Steven_Z._Pavletic

  • Ulcerative colitis
  • Inflammatory bowel disease that causes ulcers in the colon

    on histology. In patients who have undergone transplantation, graft versus host disease may also be a differential diagnosis. This response to transplantation

    Ulcerative colitis

    Ulcerative colitis

    Ulcerative_colitis

  • Vanishing bile duct syndrome
  • Medical condition

    cirrhosis Primary sclerosing cholangitis Hodgkin's lymphoma Chronic graft-versus-host disease Drugs(chlorpromazine)/Toxins Ischemia Treatment is dependent upon

    Vanishing bile duct syndrome

    Vanishing_bile_duct_syndrome

  • Maraviroc
  • Antiretroviral drug

    graft-versus-host disease". N. Engl. J. Med. 367 (2): 135–145. doi:10.1056/NEJMoa1201248. PMC 3568501. PMID 22784116. "HIV Drug Reduces Graft-versus-Host

    Maraviroc

    Maraviroc

    Maraviroc

  • Longitudinal erythronychia
  • Medical condition

    Darier's disease and lichen planus but has also occasionally been associated with acantholytic epidermolysis bullosa, no association, graft-versus-host disease

    Longitudinal erythronychia

    Longitudinal_erythronychia

  • PUVA therapy
  • Ultraviolet light therapy treatment

    ultraviolet light therapy treatment for skin diseases: vitiligo, eczema, psoriasis, graft-versus-host disease, mycosis fungoides, large plaque parapsoriasis

    PUVA therapy

    PUVA_therapy

  • Rich Cronin
  • American singer and rapper (1974–2010)

    to complications from medicine he was taking to offset GVHD (graft-versus-host disease), which he had been struggling with after having a stem cell transplant

    Rich Cronin

    Rich_Cronin

  • Immunosuppressive drug
  • Drug that inhibits activity of immune system

    immunosuppressants to prevent the acute transplant rejection and graft-versus-host disease. Nevertheless, they do not prevent an infection and also inhibit

    Immunosuppressive drug

    Immunosuppressive drug

    Immunosuppressive_drug

  • Osiris Therapeutics
  • Medical research company

    Prochymal or remestemcel-L, which was approved for pediatric Graft-versus-Host Disease (GvHD). Prochymal is a mesenchymal stem cell therapy derived from

    Osiris Therapeutics

    Osiris_Therapeutics

  • Ductopenia
  • ductopenia include failing liver transplant, Hodgkin's lymphoma, graft-versus-host disease (GVHD), sarcoid, cytomegalovirus infection, HIV, and medication

    Ductopenia

    Ductopenia

  • Bronchiectasis
  • Permanent enlargement of the lung airways

    ulcerative colitis and Crohn's disease also have an association with bronchiectasis. Additionally, graft-versus-host disease in patients who have undergone

    Bronchiectasis

    Bronchiectasis

    Bronchiectasis

  • Oral mucosa
  • Mouth-lining mucous membrane

    is done for definitive diagnosis of lichen planus. Graft-versus-host disease: An autoimmune disease developed following bone marrow transplant in which

    Oral mucosa

    Oral_mucosa

  • Histocompatibility
  • Tissue compatibility between individuals

    require higher degrees of matching due to the increased risk of graft-versus-host disease, in which the donor's immune system recognizes the recipient's

    Histocompatibility

    Histocompatibility

  • Microchimerism
  • Presence of cells originating from another individual

    might trigger a graft-versus-host reaction leading to autoimmune disease. This offers a potential explanation for why many autoimmune diseases are more prevalent

    Microchimerism

    Microchimerism

    Microchimerism

  • Gavilimomab
  • Monoclonal antibody

    immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. Gavilimomab proved slightly less

    Gavilimomab

    Gavilimomab

  • Human blood group systems
  • Blood antigen set classification systems

    disease of the newborn. It is also used before hematopoietic stem cell transplantation, as it may be responsible for some cases of acute graft-versus-host

    Human blood group systems

    Human_blood_group_systems

  • E. Donnall Thomas
  • American hematologist

    failed series of experimental treatments for leukemia and for Graft-versus-host disease at Seattle's Fred Hutchinson Cancer Research Center from 1981

    E. Donnall Thomas

    E. Donnall Thomas

    E._Donnall_Thomas

  • Spleen transplantation
  • Transfer of spleen or its fragments from one individual to another

    Splenectomy – Surgical removal of the spleen Wu; et al. (January 2011). "Graft-versus-host disease after intestinal and multivisceral transplantation". Transplantation

    Spleen transplantation

    Spleen_transplantation

  • Salivary gland disease
  • Medical condition

    red patches or spots on a white background. Sjögren's syndrome Graft-versus-host disease Post-irradiation sialadenitis Sarcoidosis—there may be parotitis

    Salivary gland disease

    Salivary gland disease

    Salivary_gland_disease

  • Respiratory syncytial virus
  • Species of virus

    to life-threatening lung disease characterized by immune dysregulation. RSV has evolved numerous strategies to evade the host's antiviral response, with

    Respiratory syncytial virus

    Respiratory syncytial virus

    Respiratory_syncytial_virus

  • Severe combined immunodeficiency
  • Genetic disorder leading to severe impairment of the immune system

    be depleted of all mature T cells to avoid the occurrence of graft-versus-host disease (GVHD). Consequently, a functional immune system takes longer

    Severe combined immunodeficiency

    Severe combined immunodeficiency

    Severe_combined_immunodeficiency

  • Omidubicel
  • Allogenic cord blood cell therapy

    blood. The most common adverse reactions include infections, graft-versus-host disease, and infusion reactions. Omidubicel is composed of human allogeneic

    Omidubicel

    Omidubicel

  • Packed red blood cells
  • Red blood cells separated for blood transfusion

    transfusion reactions including fatal transfusion-associated graft-versus-host disease (TA-GvHD), irradiation is damaging to the red blood cell membrane

    Packed red blood cells

    Packed red blood cells

    Packed_red_blood_cells

  • HLA-DP
  • Human antigen receptor of the HLA group

    HLA-DP is a protein/peptide-antigen receptor and graft-versus-host disease antigen that is composed of 2 subunits, DPα and DPβ. DPα and DPβ are encoded

    HLA-DP

    HLA-DP

  • Shwachman–Diamond syndrome
  • Medical condition

    aspects of disease. However, SDS patients have an elevated occurrence of BMT-related adverse events, including graft-versus-host disease (GVHD) and toxicity

    Shwachman–Diamond syndrome

    Shwachman–Diamond syndrome

    Shwachman–Diamond_syndrome

  • Microtransplantation
  • transplant-related mortality. Practices of microtransplantation has shown none graft-versus-host disease (GVHD) till present, thus immunosuppressive drugs for relieving

    Microtransplantation

    Microtransplantation

  • Resimmune
  • Experimental cancer drug

    lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant

    Resimmune

    Resimmune

  • HSPA1L
  • Protein-coding gene in the species Homo sapiens

    extensive number of cancers, neurodegenerative diseases, cell senescence and aging, and Graft-versus-host disease. This gene encodes a 70kDa heat shock protein

    HSPA1L

    HSPA1L

    HSPA1L

  • Zolimomab aritox
  • Monoclonal antibody

    investigated for the treatment of systemic lupus erythematosus and graft-versus-host disease, but the studies failed to show positive effects of the drug.

    Zolimomab aritox

    Zolimomab_aritox

  • Ursodeoxycholic acid
  • Medication and metabolite of cholesterol

    atresia. It is not effective in liver allograft rejection, and in graft-versus-host disease involving the liver.[medical citation needed] Diarrhea was the

    Ursodeoxycholic acid

    Ursodeoxycholic acid

    Ursodeoxycholic_acid

  • Lenzilumab
  • Chemical compound

    PMC 7033370. PMID 31880771. Tugues S, et al. (2018). "Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid

    Lenzilumab

    Lenzilumab

  • Hairy leukoplakia
  • Benign lesion on the side of the tongue due to Epstein-Barr virus

    immunosuppressive medication. OHL may also accompany chronic graft versus host disease. Even more rare are reports of OHL in persons with competent immune

    Hairy leukoplakia

    Hairy_leukoplakia

  • University of Michigan Rogel Cancer Center
  • all prostate cancers Developing new potential treatments for graft-versus-host disease Creating new mouse models to facilitate research in cancer biology

    University of Michigan Rogel Cancer Center

    University of Michigan Rogel Cancer Center

    University_of_Michigan_Rogel_Cancer_Center

  • Tacrolimus
  • Immunosuppressive drug

    Cai C, Tang Y, et al. (June 2020). "Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell

    Tacrolimus

    Tacrolimus

    Tacrolimus

  • Thymus
  • Endocrine gland

    condition is virtually indistinguishable from graft versus host disease. Myasthenia gravis is an autoimmune disease most often caused by antibodies that block

    Thymus

    Thymus

    Thymus

Searches for online references containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Search references containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Search queries for Facebook and twitter posts, hashtags with GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Follow users with usernames @GRAFT VERSUS-HOST-DISEASE or posting hashtags containing #GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Top search, Social media, medium, facebook & news articles containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Searches for Acronyms & meanings containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE

Searches, Indeed job searches and job offers containing GRAFT VERSUS-HOST-DISEASE

Other words and meanings similar to

GRAFT VERSUS-HOST-DISEASE

Search in online dictionary sources & meanings containing GRAFT VERSUS-HOST-DISEASE

GRAFT VERSUS-HOST-DISEASE